REGENXBIO (RGNX)
(Delayed Data from NSDQ)
$11.67 USD
-0.02 (-0.17%)
Updated Sep 23, 2024 04:00 PM ET
After-Market: $11.69 +0.02 (0.17%) 7:58 PM ET
3-Hold of 5 3
F Value C Growth A Momentum D VGM
Regenxbio (RGNX) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$39.64 | $52.00 | $28.00 | 239.09% |
Price Target
Based on short-term price targets offered by 11 analysts, the average price target for Regenxbio comes to $39.64. The forecasts range from a low of $28.00 to a high of $52.00. The average price target represents an increase of 239.09% from the last closing price of $11.69.
Analyst Price Targets (11)
Broker Rating
Regenxbio currently has an average brokerage recommendation (ABR) of 1.09 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 11 brokerage firms. The current ABR compares to an ABR of 1.08 a month ago based on 12 recommendations.
Of the 11 recommendations deriving the current ABR, 10 are Strong Buy and one is Buy. Strong Buy and Buy respectively account for 90.91% and 9.09% of all recommendations. A month ago, Strong Buy made up 91.67%, while Buy represented 8.33%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 10 | 10 | 11 | 11 | 11 |
Buy | 1 | 1 | 1 | 1 | 1 |
Hold | 0 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 1.09 | 1.09 | 1.08 | 1.08 | 1.08 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
8/5/2024 | Not Identified | Not Identified | Strong Buy | Strong Buy |
8/2/2024 | Chardan Capital Markets | Daniil Gataulin | Strong Buy | Strong Buy |
8/1/2024 | SVB Securities | Mani Foroohar | Strong Buy | Strong Buy |
7/28/2024 | Not Identified | Not Identified | Strong Buy | Strong Buy |
6/20/2024 | Not Identified | Not Identified | Moderate Buy | Moderate Buy |
6/20/2024 | H.C. Wainwright & Co. | Yi Chen | Strong Buy | Strong Buy |
6/7/2024 | Goldman Sachs | Paul K Choi | Not Available | Strong Buy |
3/6/2024 | Robert W. Baird & Co. | Brian P Skorney | Strong Buy | Strong Buy |
1/16/2024 | UBS | Eliana Merle | Strong Buy | Strong Buy |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 1.09 |
ABR (Last week) | 1.09 |
# of Recs in ABR | 11 |
Average Target Price | $39.64 |
LT Growth Rate | 26.80% |
Industry | Medical - Biomedical and Genetics |
Industry Rank by ABR | 79 of 253 |
Current Quarter EPS Est: | -1.16 |
RGNX FAQs
REGENXBIO Inc. (RGNX) currently has an average brokerage recommendation (ABR) of 1.09 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 11 brokerage firms.
The average price target for REGENXBIO Inc. (RGNX) is $39.64. The current on short-term price targets is based on 4 reports.
The forecasts for REGENXBIO Inc. (RGNX) range from a low of $28 to a high of $52. The average price target represents a increase of $239.67 from the last closing price of $11.67.
The current UPSIDE for REGENXBIO Inc. (RGNX) is 239.67%
Based on short-term price targets offered by 11 analysts, the average price target for Regenxbio comes to $39.64. The forecasts range from a low of $28.00 to a high of $52.00. The average price target represents an increase of 239.09% from the last closing price of $11.69.